Leukemia Home > Campath Precautions
When treating B-cell chronic lymphocytic leukemia with Campath® (alemtuzumab), some people experience serious, life-threatening infusion reactions during or shortly after receiving the drug. Infusion reactions may be more likely to occur in the first week of treatment, but can happen at any time.
Certain precautions will be taken to help reduce the risk of an infusion reaction with Campath. For example, your dosage will be slowly increased to allow your body time to get used to the medication. Also, your healthcare provider will give you medicines shortly before your dose to help decrease your risk.
(Click Campath Warnings and Precautions to learn more about how to ensure a safe treatment process with this drug and potentially serious complications that may occur.)